Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2013

View Archived Issues

Avagacestat studied in predementia Alzheimer's disease in phase II trial

Preclinical anticancer efficacy demonstrated for AKB-9778

Novel technique developed to reprogram iPSCs to treat hemophilia

Enteris BioPharma officially launches business and development activities

Sanofi reports highlights of second quarter 2013

Cardium files new 510(k) submission with FDA for Excellagen wound care product

Regen obtains license to ddRNAi gene silencing technology

Lee's Pharmaceutical files to perform pivotal trial of gimatecan for ovarian cancer in China

Piramal Enterprises receives IND clearance from FDA for novel DGAT1 inhibitor

Affymetrix launches OncoScan FFPE Assay Kit for degraded FFPE solid tumor samples

A small-molecule PDE7 inhibitor for the treatment of neurodegenerative disorders described

gIcare Pharma begins phase II trial of GIC-1001 in sedation-free colonic analgesia

Medeia Therapeutics presents new androgen receptor antagonists

Study to explore connection between celiac disease and type 1 diabetes begins

Athersys receives grant to advance MultiStem regenerative medicine program

Researchers at Genosco and Oscotec synthesize novel SYK inhibitors

Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv

Chinese researchers divulge new c-Met inhibitors

Novartis phase III study of Afinitor in advanced liver cancer does not meet primary endpoint

Daiichi Sankyo designs new agents for diabetes and obesity

Japanese group reports novel FGFR inhibitors to be useful for cancer

First patient treated with Civacir after liver transplantation in phase III trial

GSK files for use of Votrient as maintenance therapy for advanced ovarian cancer in the E.U.

GSK files MAA with EMA for use of Cervarix in two-dose schedule

Rexahn begins dosing in phase I trial of Supinoxin in solid cancer tumors

Bavarian Nordic obtains European approval for Imvanex smallpox vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...